New Jersey established the NJPMP database in September 2011, and to date, the NJPMP contains 54 million records of prescription drug prescribing and dispensing. “We must work across state lines to establish a coordinated approach to fighting painkiller abuse and prescription drug diversion, and these interstate partnerships are a critical part of this work.” “No state is an island when it comes to addressing the national issue of prescription drug abuse,” Acting Attorney General John J. These new partnerships help permit prescribers and pharmacists to identify potential misuse of prescriptions across multiple states, including prescriptions for opiate-based pain medication. Every new state that joins the New Jersey Prescription Monitoring Program interconnect fortifies our efforts to combat this national epidemic and save lives.” “Prescribers and pharmacists in these states are now our allies in identifying and flagging suspicious behaviors indicative of doctor shopping and other prescription drug misuse. “New Jersey welcomes Rhode Island, Virginia and Minnesota to our growing network of states united in the fight against prescription drug abuse and addiction,” said Governor Christie. Rhode Island, Virginia and Minnesota are the three states that recently established interconnectivity between the NJPMP and their respective prescription monitoring programs, joining Delaware and Connecticut. Trenton, NJ – The New Jersey Prescription Monitoring Program (NJPMP), a database which contains detailed information on prescriptions for Controlled Dangerous Substances (CDS) and human growth hormone, is now actively sharing data with a total of five states, Governor Chris Christie announced today. Partnership Further Expands State’s Fight Against Prescription Drug Abuse
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |